Brussels 'will block' Government's intervention in AstraZeneca deal, competition lawyers warn
Friday 09 May 2014
Competition lawyers have warned Brussels will stop ministers from intervening in Pfizer’s £63 billion takeover bid for AstraZeneca,
David Cameron has demanded further commitments from Pfizer over what would be Britain’s largest foreign takeover, and bosses from both the US pharmaceuticals giant and Astra face a grilling in Parliament next week, while Business Secretary Vince Cable has proposed that the takeover could be subjected to a “public interest test”.
But the European Commission allows intervention by national governments only in exceptional cases — and lawyers warned that this was unlikely to be one of them.
“It’s going to be very hard for the Government to intervene,” Anthony Woolich, a competition partner at the law firm Holman Fenwick Willan, told Reuters. “The whole point about the European Commission is that where you have big mergers they should be regulated centrally, and individual member states should not be able to intervene except on exceptional grounds.”
Across the Atlantic, Pfizer — which has had two approaches rebuffed by Astra — is also facing a growing body of opposition as US politicians begin voicing concerns over jobs and taxes.
Senior Democratic senators Carl Levin and Ron Wyden said they were investigating quick ways to close the loophole whereby US companies can avoid local corporation taxes by basing their tax domiciles in low-tax jurisdictions like Britain. Pfizer admits moving its tax address to the UK is a key motivation for the deal.
Today it emerged that two US governors have written to Pfizer chief executive Ian Read expressing “deep concern” about the potential impact of the takeover on “good, family-sustaining jobs”, particularly in the light of Read’s pledge to safeguard a percentage of UK roles.
Governors Martin O’Malley and Jack Markell said the company has yet to make similar pledges to workers in the states of Maryland and Delaware, where Astra employs 3,100 and 2,600 people respectively.
Shares in Astra today dipped 1 per cent to 4663p, having risen yesterday on speculation Pfizer could make a third approach, worth more than 5300p a share.
- 1 Drugs Live cannabis trial: Hash is less harmful than any other drug, expert claims
- 2 Have sex with your iPad thanks to the new sex toy no-one asked for
- 3 The 'sex selfie stick' lets you FaceTime the inside of a vagina
- 4 Adam Levine's biggest fan had a panic attack upon meeting him, so the singer laid down on the floor to get a photo with him
- 5 Why you're almost certainly more like your father than your mother
Out-of-touch MPs ‘don’t get it’, says ex-Civil Service chief
Mark Zuckerberg: Facebook CEO's one simple test for who to hire
Bali nine: Welcome to 'Execution Island' – the Indonesian holiday resort where foreigners are sent to die
'A girl is more responsible for rape than a boy': The statement that shocked the world... except India
The 'sex selfie stick' lets you FaceTime the inside of a vagina
Durham Free School: 'Creationism taught at' free school facing closure
Nearly 100,000 of Britain's poorest children go hungry after parents' benefits are cut
Ukip would cut billions from Scottish budget to fund English tax cuts
End of the licence fee: BBC to back radical overhaul of how it is funded
Ukraine crisis: Top Chinese diplomat backs Putin and says West should 'abandon zero-sum mentality'
Boris Nemtsov shot dead: Outspoken Putin critic who had expressed fears for his life is killed near the Kremlin
iJobs Money & Business
£8 per hour: Recruitment Genius: This Pension Specialist was established early...
£30 - 35k + Bonus & Benefits: Guru Careers: We are seeking an Executive Assist...
£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...
Voluntary post, reasonable expenses reimbursed: Reach Volunteering: Would you ...